BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3124752)

  • 1. Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F.
    Legler G; Bieberich E
    Arch Biochem Biophys; 1988 Jan; 260(1):437-42. PubMed ID: 3124752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of formation of complex oligosaccharides by the glucosidase inhibitor bromoconduritol.
    Datema R; Romero PA; Legler G; Schwarz RT
    Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6787-91. PubMed ID: 6757922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes.
    Grabowski GA; Osiecki-Newman K; Dinur T; Fabbro D; Legler G; Gatt S; Desnick RJ
    J Biol Chem; 1986 Jun; 261(18):8263-9. PubMed ID: 3087971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cytosolic beta-glucosidase in guinea pig liver cells.
    Hays WS; Wheeler DE; Eghtesad B; Glew RH; Johnston DE
    Hepatology; 1998 Jul; 28(1):156-63. PubMed ID: 9657108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bromoconduritol on glucosidase II from rat liver. A new kinetic model for the binding and hydrolysis of the substrate.
    Alonso JM; Santa-Cecilia A; Calvo P
    Eur J Biochem; 1993 Jul; 215(1):37-42. PubMed ID: 8344283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of alpha-glucosidase by the active-site-directed inhibitor, conduritol B epoxide.
    Yang SJ; Ge SG; Zeng YC; Zhang SZ
    Biochim Biophys Acta; 1985 Apr; 828(3):236-40. PubMed ID: 3886011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of the interaction of alkyl glycosides with two human beta-glucosidases.
    Gopalan V; Daniels LB; Glew RH; Claeyssens M
    Biochem J; 1989 Sep; 262(2):541-8. PubMed ID: 2508630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of a cytosolic beta-glucosidase from calf liver and characterization of its active site with alkyl glucosides and basic glycosyl derivatives.
    Legler G; Bieberich E
    Arch Biochem Biophys; 1988 Jan; 260(1):427-36. PubMed ID: 2963589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Glucosidase inhibition in murine peritoneal macrophages by conduritol-B-epoxide: an in vitro model of the Gaucher cell.
    Newburg DS; Yatziv S; McCluer RH; Raghavan S
    Biochim Biophys Acta; 1986 Jun; 877(1):121-6. PubMed ID: 3087427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling.
    Kuo CL; Kallemeijn WW; Lelieveld LT; Mirzaian M; Zoutendijk I; Vardi A; Futerman AH; Meijer AH; Spaink HP; Overkleeft HS; Aerts JMFG; Artola M
    FEBS J; 2019 Feb; 286(3):584-600. PubMed ID: 30600575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosolic pyridoxine-beta-D-glucoside hydrolase from porcine jejunal mucosa. Purification, properties, and comparison with broad specificity beta-glucosidase.
    McMahon LG; Nakano H; Levy MD; Gregory JF
    J Biol Chem; 1997 Dec; 272(51):32025-33. PubMed ID: 9405396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Glucosidase 2 (GBA2) activity and imino sugar pharmacology.
    Ridley CM; Thur KE; Shanahan J; Thillaiappan NB; Shen A; Uhl K; Walden CM; Rahim AA; Waddington SN; Platt FM; van der Spoel AC
    J Biol Chem; 2013 Sep; 288(36):26052-26066. PubMed ID: 23880767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the alpha-glucosidase inhibitor, bromoconduritol, on carbohydrate metabolism in the silverleaf whitefly, Bemisia argentifolii.
    Salvucci M
    Arch Insect Biochem Physiol; 2000 Nov; 45(3):117-28. PubMed ID: 11169751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial purification and characterization of Naegleria fowleri beta-glucosidase.
    Das S; Saha AK; Nerad TA; Martinez AJ; Lamarco KL; Basu A; Legler G; Glew RH
    J Protozool; 1987 Feb; 34(1):68-74. PubMed ID: 3106621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactosylsphingosine inhibition of the broad-specificity cytosolic beta-glucosidase of human liver.
    LaMarco KL; Glew RH
    Arch Biochem Biophys; 1985 Feb; 236(2):669-76. PubMed ID: 3918500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucosylceramide and the level of the glucosidase-stimulating proteins.
    Datta SC; Radin NS
    Lipids; 1986 Nov; 21(11):702-9. PubMed ID: 3099116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sites.
    Grabowski GA; Gatt S; Kruse J; Desnick RJ
    Arch Biochem Biophys; 1984 May; 231(1):144-57. PubMed ID: 6426391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of beta-glucosidase from Helix pomatia by active site-directed inhibitors.
    Donsimoni R; Legler G; Bourbouze R; Lalegerie P
    Enzyme; 1988; 39(2):78-89. PubMed ID: 2969330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of pseudo-aminosugars on oligosaccharide glucosidases I and II and on lysosomal alpha-glucosidase from rat liver.
    Takeuchi M; Kamata K; Yoshida M; Kameda Y; Matsui K
    J Biochem; 1990 Jul; 108(1):42-6. PubMed ID: 2229010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic mechanism of a family 3 beta-glucosidase and mutagenesis study on residue Asp-247.
    Li YK; Chir J; Chen FY
    Biochem J; 2001 May; 355(Pt 3):835-40. PubMed ID: 11311148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.